Valuation: Ovation Science Inc.

Market Cap 768K 545K 480K 445K 410K 52.65M 783K 5.32M 2.07M 25.79M 2.05M 2M 89.37M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 979K 695K 611K 568K 522K 67.09M 998K 6.78M 2.64M 32.86M 2.61M 2.55M 114M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.54%
Yield 2024 *
-
Yield 2025 -
Current month+33.33%
1 month+33.33%
3 months-42.86%
6 months-50.00%
Current year-50.00%
1 month 0.02
Extreme 0.02
0.02
Current year 0.02
Extreme 0.015
0.04
1 year 0.02
Extreme 0.015
0.05
3 years 0.01
Extreme 0.01
0.08
5 years 0.01
Extreme 0.01
0.14
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Director of Finance/CFO 63 2023-10-29
Chief Executive Officer 77 2017-10-03
Director TitleAgeSince
Director/Board Member 77 2017-10-03
Director/Board Member 63 2017-10-03
Director/Board Member 60 2018-02-01
Date Insider Type Main position Quantity % Market Cap.
4/7/25 Buy

Director

100,000 0.2642%
1/31/25 Buy

Director

100,000 0.2642%
1/31/25 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-66.67%0.00% 545K
-3.10%-2.58%+0.24%-10.29% 232B
-2.73%+1.62%+37.42% - 50.19B
+3.50%-4.02%+108.10% - 9.06B
+2.17%+4.07%+32.85%-50.30% 7.45B
+1.80%-1.49%-11.66%+15.31% 4.91B
-3.64%+2.60%-34.38%-31.78% 4.66B
-2.02%-0.50%-9.72%-9.31% 3.91B
-0.36%-2.87%-29.72%-47.74% 3.39B
-9.82%-10.37%-27.17%-52.61% 2.61B
Average -1.42%+0.68%-0.07%-23.34% 31.81B
Weighted average by Cap. -2.68%+1.05%+8.59%-12.24%

Financials

2024 2025
Net sales 113K 80.34K 70.67K 65.65K 60.4K 7.76M 115K 784K 306K 3.8M 302K 295K 13.17M 67.89K 48.17K 42.38K 39.37K 36.22K 4.65M 69.19K 470K 183K 2.28M 181K 177K 7.9M
Net income -456K -324K -285K -265K -243K -31.26M -465K -3.16M -1.23M -15.31M -1.22M -1.19M -53.07M -631K -448K -394K -366K -337K -43.26M -643K -4.37M -1.7M -21.19M -1.68M -1.65M -73.43M
Net Debt 265K 188K 166K 154K 141K 18.17M 270K 1.84M 716K 8.9M 707K 692K 30.85M 211K 150K 132K 122K 112K 14.44M 215K 1.46M 569K 7.07M 562K 550K 24.52M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
Date Price Change Volume
26-07-23 $0.000000 - 100
  1. Stock Market
  2. Stocks
  3. OVAT Stock